Deep Insight

Deep Context

Deep Experience

Advising, Investing, Building at the Intersection of AI and Biology

Deep Context

  • 600+ Companies

  • 250,000+ Research Publications

  • 1,000+ Researchers and Executives

A fully proprietary technical and commercial deep dive knowledge engine covering tens of thousands of research papers, company profiles, industry news and events, and ecosystem professionals.

For details: D3

Deep Insight

  • Technical and Strategic Writing

  • Speaking and Panel Engagements

  • Industry Network

Deep Experience

  • Commercial: Scratch to Scale

  • IP, Finance, R&D

  • Biology, Software, Engineering

I write the Techbio<>Biotech Substack which counts Fortune 100 CEOs, VCs, and leading industry researchers among its subscribers. I have written for the Timmerman Report, Forbes, and a host of other outlets, served on various panels with executive leaders at the FDA and venture capital funds on topics related to AI and Drug Discovery and am an alumni of the Timmerman Traverse biophama alumni network.

For details: Insights

I have twice built commercial territories/teams/organizations from scratch to 8+ figure annual revenue. I have been part of teams that have collectively raised significant venture financing and have led one of the first successful IP patent invalidation challenges in the CRISPR field.

In my spare time, I built a RAG for scientific literature, learned the underlying math of deep learning, invested in and advised a host of techbio companies and emerging funds and generally found this whole field fascinating.

For Details: About

For Techbio<>Biotech Updates Subscribe Here